Some evidence indeed suggests that the presence of PEW and inflammation may justify the observed reverse association between homocysteine and clinical outcome in CKD and ESRD patients [34,35,36,37]
This is not a complete list of side effects, and others may occur
A randomized, controlled, blinded human trial of GHK-Cu monotherapy, with a vehicle-only control (and a needling-plus-vehicle arm if a procedure is used), objective endpoints such as blinded global photography and target-area hair counts over at least several months, adequate statistical power, pre-registration, and independent replication
Proprietary data sets on adherence patterns, novel coaching methodologies, or predictive side-effect management can all serve as defensible IP